Metastatic liver disease of colorectal origin: The value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study

Hepato-Gastroenterology

Volumn 48, Issue 42, 2001, Pages 1685-1691

  Lygidakis, N J ^a   Sgourakis, G ^a   Vlachos, L ^a   Raptis, S ^a   Safioleas, M ^a   Boura, P ^a   Kountouras, J ^a   Alamani, Ma ^a  

^a NONE   (Greece)

Author keywords

Hepatectomies; Liver cancer; Liver chemotherapy; Liver resection; Liver surgery

Indexed keywords

FLUOROURACIL; FOLINIC ACID; INTERLEUKIN 2; IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE; MITOMYCIN C; PARACETAMOL;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PELVIS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; IMMUNOTHERAPY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0035658785     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Intraportal chemotherapy for colorectal hepatic metastases
2. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
3. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial
4. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
5. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomised trial
6. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
7. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy - Immunotherapy for metastatic colorectal liver cancer. A new look at an old problem
8. Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases
9. Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma
10. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases
11. Hepatic arterial infusion after hepatectomy for liver metastases of colorectal carcinoma to prevent residual hepatic recurrence
12. Adjuvant he-patic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: A pilot study
13. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases
14. Hepatic arterial infusion of interleukin-2 Based Immunochemotherapy in the treatment of unresectable liver metastases from Colorectal Cancer
15. Long term effects of hepatic arterial interleukin-2-based immunochemotherapy after potentially curative resection of colorectal liver metastases
16. Lyses of endothelial cells by autologous lymphokine-activated killer cells
17. Hepatic arterial infusion of interleukin-2 in advanced hepatocellular carcinoma
18. Augmentation of NK activity and macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin-2
19. Enhanced killing capacity of human Kupffer cells after activation with human granulocytes/macrophage colony stimulating factor and Interferon-I
20. Locoregional Immunotherapy for non resectable in malignant liver disease
21. In vivo induction of lymphokine activated killer cells by Interleukin-2 splenic artery perfusion in advanced malignancies
22. Combined treatment of unresectable hepatoma by continuous splenic arterial infusion of IL2 and intermittent hepatic arterial infusion of Anticancer Drugs
23. Clinical trials of intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer
24. Management of advanced intraabdominal malignancy using high dose intra-arterial chemotherapy with concomitant hemofiltration
25. Modulations of the activity of the promoter of the Human MDRI gene by ras and 153
26. Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodol
27. Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium
28. In vivo microscopy of the liver after injection of lipiodol into the hepatic artery and portal vein in the rat
29. Blood supply and drug delivery to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling
30. Intraarterial infusion chemotherapy for metastatic liver tumor using multiple anti-cancer agents suspended in a lipid contrast medium
31. Histological Analysis of hepatocellular carcinoma treated by intraarterial combined immuno- chemotherapy
32. Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma
33. Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2
34. Tumour immunity
35. New epidemiological data on liver oncogenesis
36. Transplenic and transtumoral in vivo immunostimulation: Effect on cellular immunity parameters